Green-light fundus autofluorescence in diabetic macular edema

International Journal of Ophthalmology

Volumn 6, Issue 1, 2013, Pages 75-80

  Reznicek, Lukas ^a   Dabov, Simeon ^a   Haritoglou, Christos ^a   Kampik, Anselm ^a   Kernt, Marcus ^a   Neubauer, Aljoscha S ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Diabetic macular edema; Fundus autofluorescence; Optical coherence tomography

Indexed keywords

EID: 84885875415     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2013.01.16     Document Type: Article

References (44)

1. Chew EY, Klein ML, Ferris FL, 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114(9):1079-1084.
2. Ferris FL, 3rd, Patz A. Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol. 1984;28(Suppl):452-461.
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102(1):7-16.
4. Moss SE, Klein R, Klein BE The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998-1003.
5. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796-1806.
6. Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008;146(5):649-655.
7. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 2005;6(4):511-524.
8. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26(9):2653-2664.
9. Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol. 1995;269(2 Pt 1):E239-246.
10. Morigi M, Angioletti S, Imberti B., Donadelli R, Micheletti G, Figliuzzi M., Remuzzi A, Zoja C, Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest. 1998;101(9):1905-1915.
11. Nishikawa T, Edelstein D, Du XL, Yamagishi S., Matsumura T, Kaneda Y, Yorek MA, Beebe D., Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404(6779):787-790.
12. Early Treatment Diabetic Retinopathy Study Research Group Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology. 1987;94(7):761-774.
13. Amsterdam A, Tajima K, Sasson R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol. 2002;64(5-6):843-850.
14. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D., Lavaque AJ, Larson RJ Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology. 2009;116(5):902-911; quiz 912-903.
15. Jonas JB, Harder B, Kamppeter BA Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2004;138(6):970-977.
16. Gillies M. Diabetic macular edema. Ophthalmology. 2009;116(3):595.
17. Chung EJ, Roh MI, Kwon OW, Koh HJ Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina. 2008;28(7):957-963.
18. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT) Retina. 2002;22(6):759-767.
19. Kook D, Wolf A, Kreutzer T., Neubauer A, Strauss R, Ulbig M., Kampik A, Haritoglou C. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina. 2008;28(8):1053-1060.
20. Roesel M, Henschel A, Heinz C., Dietzel M, Spital G, Heiligenhaus A. Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1685-1689.
21. Dandekar SS, Jenkins SA, Peto T, Scholl HP, Sehmi KS, Fitzke FW, Bird AC, Webster AR Autofluorescence imaging of choroidal neovascularization due to age-related macular degeneration. Arch Ophthalmol. 2005;123(11):1507-1513.
22. Barr DB, Beirouty ZA Autofluorescence in a patient with adult vitelliform degeneration. Eur J Ophthalmol. 1995;5(3):155-159.
23. Boon CJ, Jeroen Klevering B, Keunen JE, Hoyng CB, Theelen T. Fundus autofluorescence imaging of retinal dystrophies. Vision Res. 2008;48(26):2569-2577.
24. Datta A, Maiti A, Uparkar M. Autofluorescence imaging. Ophthalmology. 2008;115(10):1853-1854; author reply 1854.
25. Pece A, Isola V, Holz F., Milani P, Brancato R. Autofluorescence imaging of cystoid macular edema in diabetic retinopathy. Ophthalmologica. 2010;224(4):230-235.
26. Vujosevic S, Casciano M, Pilotto E., Boccassini B, Varano M, Midena E. Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci. 2011;52(1):442-448.
27. Yeung L, Lima VC, Garcia P, Landa G., Rosen RB Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology. 2009;116(6):1158-1167.
28. Wolf-Schnurrbusch UE, Wittwer VV, Ghanem R, Niederhaeuser M., Enzmann V, Framme C, Wolf S. Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest Ophthalmol Vis Sci. 2011;52(13):9497-9502.
29. Giani A, Cigada M, Choudhry N., Deiro AP, Oldani M, Pellegrini M, Invernizzi A., Duca P, Miller JW, Staurenghi G. Reproducibility of etinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150(6):815-824.
30. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P., Schlingemann RO, Sutter F, Simader C, Burian G., Gerstner O, Weichselberger A, RESTORE study group The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625.
31. Diabetic Retinopathy Clinical Research Network (DRCR.net) Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009;127(3):245-251.
32. Sakamoto A, Nishijima K, Kita M., Oh H, Tsujikawa A, Yoshimura N. Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2009;247(10):1325-1330.
33. Shin HJ, Lee SH, Chung H, Kim HC Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):61-70.
34. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M, Ferris FL, 3rd, Glassman AR, Maturi RK, Stockdale CR, Topping TM. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118:e5-e14.
35. Delori FC, Dorey CK, Staurenghi G, Arend O., Goger DG, Weiter JJ In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36(3):718-729.
36. Eldred GE, Katz ML Fluorophores of the human retinal pigment epithelium: separation and spectral characterization. Exp Eye Res. 1988;47(1):71-86.
37. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001;85(6):746-753.
38. Arend O, Weiter JJ, Goger DG, Delori FC In vivo fundus fluorescence measurements in patients with age related macular degeneration. Ophthalmologe. 1995;92(5):647-653.
39. Holz FG. Autofluorescence imaging of the macula. Ophthalmologe. 2001;98(1):10-18.
40. Su DH, Friedman DS, See JL, Chew PT, Chan YH, Nolan WP, Smith SD, Huang D., Zheng C, Li Y, Foster PJ, Aung T. Degree of angle closure and extent of peripheral anterior synechiae: an anterior segment OCT study. Br J Ophthalmol. 2008;92(1):103-107.
41. Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H., Dufier JL, Odent S, Postel-Vinay A, Janin N, Briard ML, Frézal1 J, Munnich1 A. A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet. 1993;5(3):308-311.
42. Hammer M, Konigsdorffer E, Liebermann C., Framme C, Schuch G, Schweitzer D., Strobel J. Ocular fundus autofluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246(1):105-114.
43. Srinivasan VJ, Adler DC, Chen Y, Gorczynska I., Huber R, Duker JS, Schuman JS, Fujimoto JG Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head. Invest Ophthalmol Vis Sci. 2008;49(11):5103-5110.
44. Kagemann L, Ishikawa H, Wollstein G., Brennen PM, Townsend KA, Gabriele ML, Schuman JS Ultrahigh-resolution spectral domain optical coherence tomography imaging of the lamina cribrosa. Ophthalmic Surg Lasers Imaging. 2008;39(4 Suppl):S126-131.